Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-017287
Filing Date
2009-03-31
Accepted
2009-03-31 09:50:33
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v144360_10-k.htm 10-K 1097575
2 v144360_ex10-11.htm EX-10.11 528407
3 GRAPHIC graphic1.jpg GRAPHIC 39353
4 GRAPHIC graphic2.jpg GRAPHIC 102270
5 GRAPHIC logo.jpg GRAPHIC 4384
6 v144360_ex23-1.htm EX-23.1 2852
7 v144360_ex31-1.htm EX-31.1 16330
8 v144360_ex31-2.htm EX-31.2 15975
9 v144360_ex32-1.htm EX-32.1 7256
10 v144360_ex32-2.htm EX-32.2 6729
  Complete submission text file 0001144204-09-017287.txt   1878314
Mailing Address 4 CAMPUS DRIVE SECOND FLOOR PARSIPPANY NJ 07054
Business Address 4 CAMPUS DRIVE SECOND FLOOR PARSIPPANY NJ 07054 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52153 | Film No.: 09716274
SIC: 2834 Pharmaceutical Preparations